Show simple item record

dc.contributor.authorLetelier, Pablo
dc.contributor.authorEncina, Nicole
dc.contributor.authorMorales, Pablo
dc.contributor.authorRiffo, Alejandra
dc.contributor.authorSilva, Halett
dc.contributor.authorRiquelme, Ismael
dc.contributor.authorGuzmán, Neftalí
dc.date.accessioned2021-09-28T13:20:00Z
dc.date.available2021-09-28T13:20:00Z
dc.date.issued2021
dc.identifier10.5937/jomb0-29341
dc.identifier.issn14528258
dc.identifier.urihttps://hdl.handle.net/20.500.12728/9565
dc.description.abstractCOVID-19 is an infectious disease caused by the SARSCoV- 2 virus, which has given rise to a global sanitary emergency. The clinical characteristics of COVID-19 are varied and can range from an asymptomatic infection to a mild to severe pneumonia. Recent studies have shown that different laboratory parameters become altered in these patients, and as such are useful as biomarkers to assess the progression of the disease and categorize patients that may present a severe and/or fatal clinical condition. This review analyzes biochemical and immunological markers that become altered in COVID-19 patients and their impact on different organs at a hepatic, cardiac, renal and pancreatic level, as well as markers of inflammation, analyzing their implications in the evolution of the disease.es_ES
dc.language.isoenes_ES
dc.publisherSociety of Medical Biochemists of Serbiaes_ES
dc.subjectBiomarkerses_ES
dc.subjectCoronavirus diseasees_ES
dc.subjectCOVID-19es_ES
dc.subjectLaboratory diagnosises_ES
dc.subjectSARS-CoV- 2es_ES
dc.titleRole of biochemical markers in the monitoring of covid-19 patientses_ES
dc.typeArticlees_ES


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record